Evaluation of expression of CD15 and sCD15 in non-small cell lung cancer.

International journal of oncology

Volumn 15, Issue 6, 1999, Pages 1081-1089

  Kadota, A ^a   Masutani, M ^a   Takei, M ^a   Horie, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETYLNEURAMINYL (2 3) GALACTOSYL (1 4) (FUCOPYRANOSYL (1 3)) N ACETYLGLUCOSAMINE; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; CD15 ANTIGEN; OLIGOSACCHARIDE; TUMOR ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CANCER STAGING; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RABBIT; RISK FACTOR; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD15; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGOSACCHARIDES; PROGNOSIS; RABBITS; RISK FACTORS; SURVIVAL ANALYSIS;

MLCS; MLOWN;

EID: 0033451157     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.6.1081     Document Type: Article

References (0)